Patients on the 7.2 mg weekly dose achieved an average weight loss of 20.7% of starting body weight over 72 weeks, compared to 17.5% at the standard 2.4 mg dose
Together, these emerging therapies paint a promising picture of the future: the management of AR will no longer be limited to symptom control but will advance into a new era defined by precision treatment, combination regimens, immune restoration, and potentially even a definitive cure
When Sermorelin binds to GHRH receptors on pituitary cells called somatotrophs, it triggers the release of stored growth hormone into the bloodstream
So a person managing type 2 diabetes on Ozempic and a person managing weight on Wegovy are typically not taking the same amount of semaglutide, even though the molecule is the same
Previous adjuvant drug therapies have been less effective
Many patients begin seeing lower readings within 6-12 weeks as weight loss accumulates, though individual timelines vary considerably